Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Long-term epidemiologic longitudinal study on the effect of vaccines on public inoculation.

Matsuoka I, Matsuoka T, Matsuoka A, Shigemura T, Agematsu K, Koike K.

Turk J Pediatr. 2012 Jul-Aug;54(4):376-81.

PMID:
23692718
[PubMed - indexed for MEDLINE]
Free Article
2.

Characterizing vaccine-associated risks using cubic smoothing splines.

Brookhart MA, Walker AM, Lu Y, Polakowski L, Li J, Paeglow C, Puenpatom T, Izurieta H, Daniel GW.

Am J Epidemiol. 2012 Nov 15;176(10):949-57. doi: 10.1093/aje/kws158. Epub 2012 Oct 25.

PMID:
23100246
[PubMed - indexed for MEDLINE]
Free Article
3.

Management of chickenpox with frozen mother's milk.

Verd S, López E.

J Altern Complement Med. 2012 Aug;18(8):808-10. doi: 10.1089/acm.2011.0472. Epub 2012 Jul 30.

PMID:
22845343
[PubMed - indexed for MEDLINE]
Free Article
4.

Herpes zoster in a partially vaccinated pediatric population in central Israel.

Stein M, Cohen R, Bromberg M, Tasher D, Shohat T, Somekh E.

Pediatr Infect Dis J. 2012 Sep;31(9):906-9. doi: 10.1097/INF.0b013e31825d33f9.

PMID:
22627868
[PubMed - indexed for MEDLINE]
5.

Gianotti-Crosti syndrome following childhood vaccinations.

Retrouvey M, Koch LH, Williams JV.

Pediatr Dermatol. 2013 Jan-Feb;30(1):137-8. doi: 10.1111/j.1525-1470.2011.01636.x. Epub 2011 Dec 6. Review.

PMID:
22141410
[PubMed - indexed for MEDLINE]
6.

Safety of a second dose of varicella vaccine administered at 4 to 6 years of age in healthy children in Argentina.

Fridman D, Monti A, Bonnet MC, Armoni J, Stamboulian D.

Hum Vaccin. 2011 Oct;7(10):1066-71. doi: 10.4161/hv.7.10.17816. Epub 2011 Oct 1.

PMID:
21989288
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Vaccine-related varicella-zoster rash in a hospitalized immunocompetent patient.

Bernstein P, Furuya Y, Steinberg S, Scully B, Larussa P, Gershon AA.

Am J Infect Control. 2011 Apr;39(3):247-9. doi: 10.1016/j.ajic.2010.06.027. Epub 2011 Jan 26.

PMID:
21269735
[PubMed - indexed for MEDLINE]
8.

Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months.

Knuf M, Zepp F, Meyer CU, Habermehl P, Maurer L, Burow HM, Behre U, Janssens M, Willems P, Bisanz H, Vetter V, Schmidt-Ott R.

Eur J Pediatr. 2010 Aug;169(8):925-33. doi: 10.1007/s00431-010-1142-6. Epub 2010 Feb 11.

PMID:
20148263
[PubMed - indexed for MEDLINE]
9.

The predilection of chickenpox exanthema to influenza vaccine injection site.

Ben-Shoshan M, Lejtenyi C, Primeau MN.

Pediatr Dermatol. 2009 Jul-Aug;26(4):481-2. doi: 10.1111/j.1525-1470.2009.00963.x.

PMID:
19689535
[PubMed - indexed for MEDLINE]
10.

Varicella-zoster vaccine virus: evolution in action.

Cohen JI.

Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):7-8. Epub 2006 Dec 21. No abstract available.

PMID:
17185410
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts.

Quinlivan ML, Gershon AA, Al Bassam MM, Steinberg SP, LaRussa P, Nichols RA, Breuer J.

Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):208-12. Epub 2006 Dec 20.

PMID:
17182747
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Enhanced chickenpox exanthema in vaccine injection site.

Hentgen V, Cohen R, Siegrist CA.

Scand J Infect Dis. 2006;38(10):920-1.

PMID:
17008239
[PubMed - indexed for MEDLINE]
13.

A new combination vaccine for measles, mumps, rubella and varicella.

Zareba G.

Drugs Today (Barc). 2006 May;42(5):321-9. Review.

PMID:
16801995
[PubMed - indexed for MEDLINE]
14.

Varicella zoster in children attending day care centers.

Marcitelli R, Bricks LF.

Clinics (Sao Paulo). 2006 Apr;61(2):147-52. Epub 2006 Apr 25.

PMID:
16680332
[PubMed - indexed for MEDLINE]
Free Article
15.

Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.

Heininger U, Desgrandchamps D, Schaad UB.

Vaccine. 2006 Apr 12;24(16):3258-60. Epub 2006 Jan 19.

PMID:
16459000
[PubMed - indexed for MEDLINE]
16.

An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.

Quinlivan M, Gershon AA, Steinberg SP, Breuer J.

J Med Virol. 2005 Jan;75(1):174-80.

PMID:
15543576
[PubMed - indexed for MEDLINE]
17.

Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.

Quinlivan ML, Gershon AA, Steinberg SP, Breuer J.

J Infect Dis. 2004 Aug 15;190(4):793-6. Epub 2004 Jul 15.

PMID:
15272408
[PubMed - indexed for MEDLINE]
Free Article
18.

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.

Nolan T, McIntyre P, Roberton D, Descamps D.

Vaccine. 2002 Dec 13;21(3-4):281-9.

PMID:
12450703
[PubMed - indexed for MEDLINE]
19.

The postmarketing safety profile of varicella vaccine.

Sharrar RG, LaRussa P, Galea SA, Steinberg SP, Sweet AR, Keatley RM, Wells ME, Stephenson WP, Gershon AA.

Vaccine. 2000 Nov 22;19(7-8):916-23.

PMID:
11115716
[PubMed - indexed for MEDLINE]
20.

Viral strain identification in varicella vaccinees with disseminated rashes.

LaRussa P, Steinberg SP, Shapiro E, Vazquez M, Gershon AA.

Pediatr Infect Dis J. 2000 Nov;19(11):1037-9. Erratum in: Pediatr Infect Dis J 2001 Jan;20(1):33.

PMID:
11099082
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk